Daniel Tasse - Director, Bellerophon Therapeutics, Inc

As of June 25, 2018


What is Daniel Tasse's Net Worth?

The current estimated net worth of Bellerophon Therapeutics, Inc's Director, Daniel Tasse, is estimated to be about $236.86K . Daniel Tasse owns about 128,898 units of Bellerophon Therapeutics, Inc common stock. In the last 3 years at Bellerophon Therapeutics, Inc, Daniel Tasse has sold an estimated value of $0 worth.

What is Daniel Tasse's Past Insider Trading?

Daniel Tasse's largest purchase order was 25,000 units , worth over $300K on February 23, 2015. In total, Daniel Tasse has made about 7 transactions over 3 years of their time at Bellerophon Therapeutics, Inc. Daniel Tasse usually trades in June, with the busiest year in 2016, 2018 and 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Daniel Tasse's' Mailing Address?

  • Mailing address is C/o Ikaria, Inc. 6 State Route 173 Clinton NJ 08809 NJ

What are Bellerophon Therapeutics, Inc's Past Insider Trades?

Bellerophon Therapeutics, Inc's most recent insider trade came on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky who sold 400,000 units worth $2.19M . In the last 6 years, insiders at Bellerophon Therapeutics, Inc have sold an estimated value of $3.99M and bought an estimated value of $74.83M worth of shares. Insider trading is most common in September, with the busiest year in 2018. The most active traders at the company are Jonathan M Peacock,  Theodore T Wang,  and Peter Fernandes, CHIEF REGULATORY & SAFETY OFFR .

Bellerophon Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1